Nearly two weeks after a CDC advisory panel voted to end the recommendation for newborn hepatitis B vaccination, conversations about vaccination schedules and parental choice remain elevated. Meanwhile, narratives about an FDA memo alleging COVID-19 vaccines caused 10 pediatric deaths have shifted toward claims of a government cover-up.
As immigrants in southeastern Louisiana and Mississippi braced for this month’s U.S. Homeland Security operation, Cristiane Rosales-Fajardo received a panicked phone call from a friend. The friend’s Guatemalan tenant, who didn’t know she was pregnant, had just delivered a premature baby in the New Orleans house. The parents lacked legal residency, and the mother refused…
WASHINGTON — Every night, Abdullah Ibrahim retreats from the streets into a wooded stretch along the Potomac River. As night falls and temperatures drop, he erects a tent and builds a fire beneath a canopy of pine, hemlock, and cedar trees. He evades authorities by rotating use of three tents of different colors at three…
For the millions of Americans who buy Affordable Care Act insurance, there’s still time left to enroll for 2026. But premium increases and the expiration of enhanced tax subsidies have led to larger-than-expected costs. Concerned shoppers, wondering if there’s anything they can do, are consulting insurance brokers or talking to representatives at ACA marketplace call…
[Sponsored] Learn how to find qualified spine surgeons for a second opinion in Los Angeles by comparing the leading options from regional medical facilities. The post Need a Second Opinion? Here Are 5 Top-Rated Spine Surgeons in Los Angeles appeared first on MedCity News.
Through a new partnership, Thatch’s employer customers can now offer Teal Health’s at-home cervical cancer screening as an employee benefit through an ICHRA. The post Teal Health Teams Up With Thatch to Expand Access to Cervical Cancer Screening appeared first on MedCity News.
GSK’s Exdensur requires just two injections a year to treat severe asthma. Less frequent injections give this new biologic medicine a dosing edge over one of GSK’s own blockbuster respiratory products as well as severe asthma drugs from companies such as AstraZeneca, Sanofi, and Amgen. The post GSK Gets FDA Approval for New Severe Asthma…
The legislative deadlock over ACA subsidies would leave many middle-income households facing higher premiums
In my latest Guest Column in The Evidence Base, II am joined by my colleague Tiago Beck as we examine how global pricing reforms are reshaping the European pharmaceutical landscape. Building on their session at ISPOR Europe 2025, the column explores the growing tension between EU access ambitions and international policy pressures – offering a…
We are on the cusp of being held accountable not just for what we did wrong, but for what we failed to do, especially when readily available, life-saving technology could have made a difference. The post When Inaction Becomes Negligence in the Age of AI appeared first on MedCity News.